Driving the innovation engine

By 1998, Celgene obtained FDA approval for its use in the treatment of leprosy. ... That year Celgene reported sales of $3.3m. Within two years the sales had grown to $62m.

New hires at Bristol-Myers Squibb, Acceleron and FerGene

Acceleron . Acceleron Pharma has poached Jay Backstrom (pictured right) from Celgene, where he worked as chief medical officer. ... Prior to Celgene, he served as vice president, global medical affairs and safety at Pharmion.

GSK files anti-BCMA drug for myeloma after second trial win

Patients in the trial had on average received seven earlier lines of therapy, including an immuno-modulatory drug such as Celgene’s Revlimid (lenalidomide), a proteasome inhibitor such as Takeda’s ... The followers include a CAR-T therapy from

Roche to close $4.3bn Spark deal after FTC clearance

Roche is not the only big pharma who has faced pushback on a planned merger from the FTC – Bristol-Myers Squibb’s takeover of Celgene was delayed by an investigation and

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]